0001209191-22-052218.txt : 20221004 0001209191-22-052218.hdr.sgml : 20221004 20221004161928 ACCESSION NUMBER: 0001209191-22-052218 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221004 DATE AS OF CHANGE: 20221004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jenkins Abigail L. CENTRAL INDEX KEY: 0001947032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38716 FILM NUMBER: 221291853 MAIL ADDRESS: STREET 1: C/O GAMIDA CELL LTD. STREET 2: 116 HUNTINGTON AVENUE CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gamida Cell Ltd. CENTRAL INDEX KEY: 0001600847 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 NAHUM HAFZADI STREET CITY: JERUSALEM STATE: L3 ZIP: 95484 BUSINESS PHONE: 97226595666 MAIL ADDRESS: STREET 1: 5 NAHUM HAFZADI STREET CITY: JERUSALEM STATE: L3 ZIP: 95484 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-30 0 0001600847 Gamida Cell Ltd. GMDA 0001947032 Jenkins Abigail L. C/O GAMIDA CELL LTD. 116 HUNTINGTON AVENUE BOSTON MA 02116 1 1 0 0 President and CEO Ordinary Shares 2022-09-30 4 P 0 16129 1.55 A 266129 D The reporting person purchased ordinary shares of the Issuer at a price of $1.55 per share in an underwritten public offering by the Issuer, which closed on September 30, 2022. /s/ Joshua F. Patterson, Attorney-in-Fact 2022-10-04